Biotech

Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility

🕔7/1/2025 8:30:25 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) is pleased to announce a major $6 million expansion of the WA Proteomics Facility, in partnership with The University of Western Australia (UWA), the WA State Government and Bioplatforms Australia.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan

🕔6/30/2025 8:24:12 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that the Japan Patent Office has granted the Company its first patent for PromarkerEndo, the proprietary diagnostic blood test for endometriosis.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease

🕔6/23/2025 8:19:55 AM

Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting DKD

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference

🕔6/20/2025 8:36:42 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, proudly announces the initial US launch of its groundbreaking predictive test for diabetic kidney disease, PromarkerD, at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis

🕔6/5/2025 9:22:12 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics is pleased to announce the publication of clinical validation results in the journal Proteomes showing its PromarkerEso blood test can diagnose esophageal adenocarcinoma with high accuracy.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) New Blood Test For Endometriosis Moves Closer to Market

🕔5/30/2025 12:34:20 PM

Proteomics International Laboratories Ltd (ASX:PIQ) has unveiled landmark clinical data confirming its Promarker(R)Endo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Latest Results Presented at World Congress

🕔5/26/2025 8:21:24 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce another milestone in the development of its PromarkerEndo diagnostic test for endometriosis.

Read Full Article